6505--Buspirone RFP | GovSignals

GovSignals

Get GovSignals Today

Our AI platform powers the best government contractors to win more.

Intelligence before the RFP

AI Matching across thousands of opportunities

Proposal and Workflow Automation

Get Started

Be the first to know, bid, and win.

Get GovSignals Today

Our AI platform helps government contractors compete with the biggest companies.

Get Started

6505--Buspirone RFP

SAM.GOV

Due: May 8, 2025 at 07:30 PM UTC

In-Active Solicitation Source Url

SAM.GOV Due: May 8, 2025 at 07:30 PM UTC

In-Active Solicitation Source Url

Summary

The opportunity titled '6505--Buspirone RFP' is a solicitation issued by the Department of Veterans Affairs for the procurement of Buspirone, a medication used to treat anxiety. This RFP is aimed at pharmaceutical companies that are capable of supplying this specific medication to meet the needs of veterans. Interested contractors should have experience in pharmaceutical manufacturing and distribution, particularly in compliance with federal regulations. The deadline for submission of proposals is May 8, 2025, and the solicitation was posted on April 24, 2025. Companies that can demonstrate their ability to deliver high-quality pharmaceutical products in a timely manner are encouraged to bid on this opportunity.

Entities: VADO
Department of Veterans Affairs
NAICS: 325412
Set Aside: None
Place of Performance
Point of Contact
Attachments: 36E79725R0024.docx

Buspirone+Amendment+0001.docx